Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis

JA Young, CR Pallas, MA Knovich - Bone Marrow Transplantation, 2021 - nature.com
Transplant-associated thrombotic microangiopathy (TA-TMA) is an increasingly recognized
complication of hematopoietic stem cell transplant (HSCT) with high morbidity and mortality …

Thrombomodulin as a physiological modulator of intravascular injury

K Watanabe-Kusunoki, D Nakazawa, A Ishizu… - Frontiers in …, 2020 - frontiersin.org
Thrombomodulin (TM), which is predominantly expressed on the endothelium, plays an
important role in maintaining vascular homeostasis by regulating the coagulation system …

Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …

L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …

A Padmanabhan, L Connelly‐Smith… - Journal of clinical …, 2019 - Wiley Online Library
ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating and categorizing …

Transplant-associated thrombotic microangiopathy in pediatric hematopoietic cell transplant recipients: a practical approach to diagnosis and management

CC Dvorak, C Higham, KA Shimano - Frontiers in Pediatrics, 2019 - frontiersin.org
Transplant-associated thrombotic microangiopathy (TA-TMA) is an endothelial damage
syndrome that is increasingly identified as a complication of both autologous and allogeneic …

Endothelial cell function and endothelial‐related disorders following haematopoietic cell transplantation

GC Hildebrandt, N Chao - British Journal of Haematology, 2020 - Wiley Online Library
Use of haematopoietic cell transplantation (HCT) in the treatment of haematologic and
neoplastic diseases may lead to life‐threatening complications that cause substantial …

The role of complement in HSCT-TMA: basic science to clinical practice

S Meri, D Bunjes, R Cofiell, S Jodele - Advances in Therapy, 2022 - Springer
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-
TMA) is a common complication occurring post-HSCT and is associated with substantial …

Advances in the diagnosis and treatment of disseminated intravascular coagulation in haematological malignancies

T Ikezoe - International journal of hematology, 2021 - Springer
Haematological malignancies, including acute leukaemia and non-Hodgkin lymphoma, are
one of the underlying diseases that frequently cause disseminated intravascular coagulation …

Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy

E Gavriilaki, VT Ho, W Schwaeble, T Dudler… - … hematology & oncology, 2021 - Springer
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-
TMA) is a life-threatening syndrome that occurs in adult and pediatric patients after …

High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease

S Kraft, N Bollinger, B Bodenmann, D Heim… - Bone marrow …, 2019 - nature.com
Transplant-associated thrombotic microangiopathy (TA-TMA) remains a major complication
of allogeneic hematopoietic stem cell transplantation (allo-HSCT). We hypothesized that TA …